Skip to search formSkip to main contentSkip to account menu

5-androstene-16-fluoro-17-one

Known as: 16alpha-Fluoroandrost-5-en-17-one, Dehydroepiandrosterone Analog 8354, FLUASTERONE 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
We compared in vivo radioprotective efficacy of 5-androstenediol (5-AED) to that of ten other steroids: 17α-androstenediol… 
Review
2004
Review
2004
  • H. Offner
  • Journal of Neuroscience Research
  • 2004
  • Corpus ID: 8019556
The extensive literature and the work from our laboratory illustrate the large number of complex processes affected by estrogen… 
Highly Cited
2003
Highly Cited
2003
The purpose of this study was to investigate the efficacy of a novel steroid, fluasterone (DHEF, a dehydroepiandrosterone (DHEA… 
2003
2003
Review
2001
Review
2001
Progress in mechanism-based cancer prevention research may be facilitated by the use of animal models displaying specific genetic… 
Highly Cited
1999
Highly Cited
1999
Solubility enhancement has broad implications in parenteral formulation design. A simple mathematical model has been developed to… 
Highly Cited
1999
Highly Cited
1999
Solubilization of nonpolar drugs constitutes one of the most important tasks in parenteral formulations design. This study… 
Review
1996
Review
1996
Clinical chemoprevention trials of more than 30 agents and agent combinations are now in progress or being planned. The most… 
Review
1994
Review
1994
Chemoprevention drug development has the goal of identifying safe and effective chemopreventive agents for clinical use. Several…